Get More Information on Sequencing Market - Request Sample Report
The Sequencing Market Size was valued at USD 13.0 Billion in 2023, and is expected to reach USD 47.29 Billion by 2032, and grow at a CAGR of 15.40% Over the forecast period of 2024-2032.
The healthcare industry is experiencing growth due to the increasing incidences of cancer and the rising demand for pharmacogenomics. Key market players are investing in the industry, and there is a growing number of collaborations and joint ventures among them, which is expected to create opportunities for market growth. For instance, in June 2022, Illumina Inc. and the Allegheny Health Network agreed to evaluate the impact of in-house Comprehensive Genomic Profiling (CGP) on patient care. The rise in inherited cancers is predicted to increase the need for modern gene editing techniques such as CRISPR-Cas gene technology, which have provided new dimensions in the treatment of cancers through various gene therapies. For example, in September 2022, a team of investigators at the University of California presented a study on the 'Clinical translation for the management of inherited retinal diseases, which requires precision genome editing agents'.
The current generation of high-throughput sequencing technologies, such as NGS and microarrays, has generated massive amounts of genomic data. However, the rapid growth in data generation from DNA sequencing and datasets like Electronic Health Records (EHRs) has created significant challenges as well as opportunities for identifying biologically or clinically important signals, such as PheWAS and GWAS for detecting genotype-phenotype associations. Several market players are focusing significantly on collaborations, expansions, acquisitions as well as major capital investments to boost the research associated with rare diseases and support drug discovery. For example, in December 2023 CCM Biosciences revealed they would introduce a new business unit called 5Prime that zeroes on next-generation DNA sequencing and beyond. This group will concentrate on molecular diagnostics and enzyme-based engineering using DNA-based biotechnology.
Key Drivers:
Advancements in Sequencing Technologies (e.g., Faster, Cheaper, and More Accurate Methods Like NGS) are Fueling the Growth of the Sequencing Market
Rising Demand for Personalized Medicine in Healthcare, which Requires Large-Scale Genomic Data is Boosting the Demand for Sequencing.
Restraints:
The High Cost of Sequencing Equipment and Infrastructure, Particularly for Third-Generation Technologies Restraining the Growth of The Market.
Data Privacy and Ethical Concerns Regarding Genetic Information Usage are Hampering the Growth of The Market.
Opportunity:
Expansion of Sequencing in Agriculture for Crop Improvement and Sustainability is posing a Lucrative Growth Opportunity for the sequencing Market.
Growth In Precision Medicine and Drug Development, driven by the Increasing Use of Sequencing in Pharmaceutical Research is Witnessed to boost Sequencing Market Growth during the Forecast period.
The sequencing technology segment was dominated by Next-Generation Sequencing (NGS), which held a market share of 65% in 2023. NGS has become the preferred choice due to its ability to process multiple samples with high throughput in a single run, making it suitable for various fields such as genomics, cancer research, and personalized medicine. The HiSeq method is currently favored for research or clinical projects requiring analysis of large numbers of DNA strands due to its cost-effectiveness and scalability, as it can sequence millions of strands simultaneously. Newer methods with higher throughput, like NGS, have surpassed Sanger sequencing, which now represents a smaller fraction of the market. However, Sanger sequencing is still widely used for high-accuracy applications, such as small-scale clinical diagnostics. Single-molecule real-time (SMRT) and Nanopore Sequencing, both third-generation sequencing technologies, hold around 20% of the market share due to their provision of long-read sequences in real-time, despite having higher costs per run compared to NGS. Due to the abundance of new technologies, NGS stands out as a versatile and essential tool for wide-ranging applications in research across various disciplines, setting a new standard for genomic-based investigations and medical applications.
Need any customization research on Sequencing Market - Enquiry Now
In 2023, Research institutions held the largest market share, accounting for 54%. This growth is attributed to the molecularization and discovery of new channels, enabling researchers to gain insights into genetic material, thereby identifying potential drug targets and gaining a deeper understanding of disease pathways. The reduced sequencing costs and wider accessibility of this technology have contributed significantly to its growth.
Next-generation sequencing, once expensive and limited to prestigious institutions, has now become more affordable for academic labs. As a result, these tools are being made available to universities and research institutions worldwide, supporting investigations in evolutionary biology and cancer genomics. Sequencing has diverse applications, including cancer research, mutation identification in tumors, and personalized treatment solutions. These advancements have deepened our understanding of cancer at a molecular level, aiding in risk assessment, early diagnosis, and treatment. Consequently, sequencing has emerged as a vital tool in cancer therapeutics and diagnostics.
The North American region dominated the market with 49% of the share in 2023 in the sequencing market. This is advantageous due to the involvement of research institutes and pharmaceutical giants. The increasing understanding of the profound implications of genetic expression for human health means that genomics is now an essential part of disease research and drug discovery. Collaborative efforts related to the applications of genomics are evident, such as Illumina's collaboration with Nashville Biosciences, LLC, a subsidiary of Vanderbilt University Medical Center, to facilitate drug development and establish clinical genomic resources.
The U.S. sequencing market is expected to expand in the coming years as a result of the rising incidence of cancer in the country. The American Cancer Society, Inc. estimates that more than 2 million new cancer cases will be diagnosed, with around 611,720 deaths from cancer anticipated by 2024. As precision medicine becomes more important in cancer treatment, the ability to sequence an individual's genes provides a deeper understanding of the genetic mutations driving the cancer. This enables doctors to tailor targeted therapies based on the genetic profile of the tumor, thus increasing the demand for sequencing technology in clinical and diagnostic applications.
Illumina: HiSeq, MiSeq, NovaSeq, NextSeq
Thermo Fisher Scientific: Ion Torrent Genexus, Ion Torrent S5 XL, Applied Biosystems 3730 DNA Analyzer
BGI Genomics: DNBSeq, BGISeq-500, BGISeq-50
Pacific Biosciences: Sequel IIe, Sequel II
Oxford Nanopore Technologies: MinION, GridION, PromethION
Roche Sequencing Solutions: 454 Sequencing System, MinION (through a partnership with Oxford Nanopore)
Agilent Technologies: SureSelect, SureTarget, SureSeq
Qiagen: GeneRead, QIAseq, GeneGlobe
PerkinElmer: GeneAmp PCR System, QuantStudio
GenScript Biotech Corporation: TruSeq, Nextera, HaloPlex
Macrogen: NGS-based sequencing services
Genewiz: NGS-based sequencing services
Eurofins Genomics: NGS-based sequencing services
Beckman Coulter: GeneAmp PCR System, QuantStudio (through a partnership with Thermo Fisher Scientific)
Fluidigm Corporation: C1 Single-Cell System, Access Array
10x Genomics: Chromium Single-Cell System, GemCode Technology
MGI Tech Co., Ltd.: DNBSeq, BGISeq-500, BGISeq-50 (through a partnership with BGI Genomics)
Nanopore Technologies: MinION, GridION, PromethION (through a partnership with Oxford Nanopore)
Azenta Life Sciences: NGS-based sequencing services
Sanger Sequencing Technology: Sanger sequencing platforms (e.g., ABI 3730 DNA Analyzer).
In December 2023, Illumina Inc. partnered with HaploX to reduce the hassle of importing expensive sequencing instruments from the US. This partnership resulted in Align being locally manufactured in China.
In March 2023, Illumina Inc. introduced its Illumina Complete Long Read technology, which represents a significant advancement for NGS (Next-Generation Sequencing) as it enables long and short reads to be generated on the same instrument.
In July 2023, Illumina Inc. introduced the QIAseq Normalizer Kits for research use. This method is popular for different DNA libraries, as it is convenient, fast, and cost-effective, providing the best-quality results from NGS runs.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 13.0 Billion |
| Market Size by 2032 | US$ 47.29 Billion |
| CAGR | CAGR of 15.40% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Technology: Sanger sequencing, Next-generation sequencing (NGS) & Third-generation sequencing. •By Application: Healthcare, Agriculture, Forensic science, Environmental science & Industrial applications. •By End-User: Research institutions, Pharmaceutical and biotechnology organizations, Government agencies & Others. |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Illumina, Thermo Fisher Scientific, BGI Genomics, Pacific Biosciences, Oxford Nanopore Technologies, Agilent Technologies, Qiagen, PerkinElmer, GenScript Biotech Corporation, Macrogen & other players |
| Key Drivers | •Advancements in Sequencing Technologies (e.g., Faster, Cheaper, and More Accurate Methods Like NGS) are Fueling the Growth of the Sequencing Market •Rising Demand for Personalized Medicine in Healthcare, which Requires Large-Scale Genomic Data is Boosting the Demand for Sequencing. |
| RESTRAINTS | •The High Cost of Sequencing Equipment and Infrastructure, Particularly for Third-Generation Technologies Restraining the Growth of The Market. •Data Privacy and Ethical Concerns Regarding Genetic Information Usage are Hampering the Growth of The Market. |
Ans: The North America led Sequencing Market.
Ans: The Sequencing Market will be valued at USD 47.29 Billion in 2032.
Ans: Next-generation sequencing (NGS) held the largest share of the Sequencing Market in 2023.
Ans: The expected CAGR of the Global Sequencing Market during the forecast period is 15.40%
Ans: The Sequencing Market was valued at USD 13.0 Billion in 2023.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume: Technology and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Technology Benchmarking
6.3.1 Technology specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Technology launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Sequencing Market Segmentation, by Technology
7.1 Chapter Overview
7.2 Sanger Sequencing
7.2.1 Sanger Sequencing Market Trends Analysis (2020-2032)
7.2.2 Sanger Sequencing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Next-generation Sequencing (NGS)
7.3.1 Next-generation Sequencing (NGS) Market Trends Analysis (2020-2032)
7.3.2 Next-Generation Sequencing (NGS) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Third-generation Sequencing
7.4.1 Third-generation Sequencing Modules Market Trends Analysis (2020-2032)
7.4.2 Third-generation Sequencing Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Sequencing Market Segmentation, by Application
8.1 Chapter Overview
8.2 Oncology
8.2.1 Oncology Market Trends Analysis (2020-2032)
8.2.2 Oncology Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Clinical Investigation
8.3.1 Clinical Investigation Market Trends Analysis (2020-2032)
8.3.2 Clinical Investigation Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Reproductive Health
8.4.1 Reproductive Health Market Trends Analysis (2020-2032)
8.4.2 Reproductive Health Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Sequencing Market Segmentation, by End-User
9.1 Chapter Overview
9.2 Research Institutions
9.2. Research Institutions Market Trends Analysis (2020-2032)
9.2.2 Research Institutions Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Pharmaceutical and biotechnology organizations
9.3.1 Pharmaceutical and biotechnology organizations Market Trends Analysis (2020-2032)
9.3. Pharmaceutical and biotechnology organizations Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Government Agencies
9.4.1 Government Agencies Market Trends Analysis (2020-2032)
9.4.2 Government Agencies Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Others
9.5.1 Others Market Trends Analysis (2020-2032)
9.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.4 North America Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.6.2 USA Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.7.2 Canada Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.8.2 Mexico Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.6.2 Poland Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.7.2 Romania Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.4 Western Europe Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.6.2 Germany Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.7.2 France Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.8.2 UK Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.9.2 Italy Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.10.2 Spain Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.13.2 Austria Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.4 Asia Pacific Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.6.2 China Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.7.2 India Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.8.2 Japan Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.9.2 South Korea Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.10.2 Vietnam Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.11.2 Singapore Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.12.2 Australia Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.4 Middle East Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.6.2 UAE Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.4 Africa Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.4 Latin America Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.6.2 Brazil Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.7.2 Argentina Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.8.2 Colombia Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Sequencing Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Illumina
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Technology/ Services Offered
11.1.4 SWOT Analysis
11.2 Thermo Fisher Scientific
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Technology/ Services Offered
11.2.4 SWOT Analysis
11.3 BGI Genomics
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Technology/ Services Offered
11.3.4 SWOT Analysis
11.4 Pacific Biosciences
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Technology/ Services Offered
11.4.4 SWOT Analysis
11.5 Oxford Nanopore Technologies
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Technology/ Services Offered
11.5.4 SWOT Analysis
11.6 Agilent Technologies
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Technology/ Services Offered
11.6.4 SWOT Analysis
11.7 Qiagen
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Technology/ Services Offered
11.7.4 SWOT Analysis
11.8 PerkinElmer
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Technology/ Services Offered
11.8.4 SWOT Analysis
11.9 GenScript Biotech Corporation
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Technology/ Services Offered
11.9.4 SWOT Analysis
11.10 Eurofins Genomics
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Technology/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Technology
Sanger sequencing
Next-generation sequencing (NGS)
Third-generation sequencing
By Application
Oncology
Clinical Investigation
Reproductive Health
Others
By End-User
Research institutions
Pharmaceutical and biotechnology organizations
Government agencies
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Antimicrobial Susceptibility Testing Market Size was valued at USD 3.57 billion in 2023 and is expected to reach USD 5.35 billion by 2031 and grow at a CAGR of 5.2% over the forecast period 2024-2031.
The Hormone Replacement Therapy Market Size was valued at USD 18.36 billion in 2023 and is expected to reach USD 29.02 billion by 2032 and grow at a CAGR of 5.31% over the forecast period 2024-2032.
The Physiotherapy Equipment Market size was estimated at USD 20.24 billion in 2023 and is expected to reach USD 38.64 billion by 2032 with a growing CAGR of 7.45% during the forecast period of 2024-2032.
The Soft Tissue Allograft Market size was valued at USD 5.11 billion in 2023 and is expected to reach USD 8.46 billion by 2032, with a growing at CAGR of 5.77% over the forecast period of 2024-2032.
The Infusion Pump Software Market Size was valued at USD 10.2 billion in 2023, and is expected to reach USD 14.72 billion by 2031 and grow at a CAGR of 4.7% over the forecast period 2024-2031.
The Medical Imaging Workstations Market Size was valued at USD 5.49 billion in 2022, and is expected to reach USD 10.02 billion by 2030 and grow at a CAGR of 7.8% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
